WENDY COCKRON: Open Payments
NPI 1679237911 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 8 payments from 7 companies in 2025. Trend: 2023 $104 · 2024 $0 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 1 | $48 |
| CSL Behring | 2 | $41 |
| Grifols USA, LLC | 1 | $36 |
| ABBVIE INC. | 1 | $27 |
| SK Life Science, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| ACADIA Pharmaceuticals Inc | 1 | $16 |
Products named: VALTOCO, Hizentra, Gamunex-C, BOTOX, KESIMPTA, NUPLAZID.
Industry payments across TX — which companies pay providers there.
